Foster, G R <br/><br/>
Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin.  [electronic resource] 

 -  Journal of viral hepatitis  Mar 2016 
 - 227-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2893 
<br/><br/><label>Standard No.: </label>10.1111/jvh.12485  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aminoisobutyric Acids<br/>Antiviral Agents--administration & dosage<br/>Female<br/>Genotype<br/>Hepacivirus--classification<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--administration & dosage<br/>Leucine--analogs & derivatives<br/>Male<br/>Middle Aged<br/>Oligopeptides--administration & dosage<br/>Placebos--administration & dosage<br/>Proline--analogs & derivatives<br/>Quinolines<br/>Ribavirin--administration & dosage<br/>Salvage Therapy--methods<br/>Thiazoles--administration & dosage<br/>Treatment Outcome